Abstract:Monoamine oxidases, prevalent in mammals, plants, and both prokaryotic and eukaryotic microorganisms, catalyze the oxidation of amines to aldehydes. They have been classified into two groups, copper(EC 1.4.3.6) and flavin-containing amine oxidases (EC 1.4.3.4). Flavin-linked mitochondrial monoamine oxidases (MAO) are subdivided further into two catalytically distinguishable subtypes with different substrate selectivities : MAO A and MAO B. They are crucial for the regulation of physiological amine levels throughout the organism. Copper-containing amine oxidases (CAO) also have important and diverse functions in prokaryotes, including roles in nutrient metabolism. More recently, the importance of CAO in eukaryotes for different physiological processes, such as wound healing, detoxification of amines, cell growth, signaling, apoptosis, and glucose uptake, was demonstrated. They constitute a wide family of enzymes covering bovine and sheep plasma amine oxidase, lysil oxidase, diamine oxidase, and a tissue-bound oxidase. Monoamine oxidases are important pharmacological and medicinal targets because of their diverse physiological roles. Selective inhibitors for different enzyme subtypes have been intensively studied. A commercially important example is tranylcypromine (1a) (trans-2-phenylcyclopropylamine, TCP, Parnate, Jatrosom N), which is an irreversible inhibitor of both MAO A and B. Additionally, 1a is a potent reversible inhibitor of copper-containing amine oxidases. Tranylcypromine has an important clinical use as a treatment for certain depressive illnesses. Recent studies also discussed MAO inhibitors as useful agents against neurodegenerative disorders such as Parkinson's or Alzheimer's diseases. Despite impressive clinical successes, clinical use of tranylcypromine (1a) and other MAO inhibitors is limited by various problems. For example, patients treated with nonselective MAO inhibitors can suffer a severe hypertensive crisis after the ingestion of tyramine-containing foods, such as cheese and red wine. This socalled TMcheese effect∫ is caused by the increase of tyramine concentration associated with the inhibition of MAO A. There has been extensive research directed toward the development of more potent and selective MAO inhibitors. In the work reviewed here, the pharmacological activity of 1a in combination with its undesired side effects prompted us to regard this molecule as the starting point for a lead-optimization process. The modifications incorporated our current interests in the chemistry and pharmacology of fluorinated compounds, interests that had recently focused on cyclopropylamines and amino acids. The goals of this optimization included increased inhibitory activity and an improved pharmacokinetic profile and selectivity. The fundamental strategy consisted of incorporation of a fluorine substituent onto the cyclopropyl moiety. The incorporation of fluorine into bioactive compounds is known to be a very effective method for the enhancement of the physiological properties of such molecules. The modifications are caused by the unique properties of fluorine. As the most electronegative element, this substituent influences the acidity/basicity of neighboring groups such as NH2. [9] Also, the lipophilicity of molecules is influenced. A fluorine substituent can mimic some properties of a hydroxy group because of its isoelectronic properties. In fact, we recently found indications both from X-ray studies of crystalline derivatives and from high-level quantum chemical calculations that a fluorine atom attached to a cyclopropyl group can act as a hydrogenbond acceptor. Another important factor comes from the observation that fluorinated cyclopropanes possess an increased ring-strain energy. Since ring-opening reactions are important for the inhibition mechanism of certain aminocyclopropanes, fluorine substitution could be expected to enhance the inhibitory activity of these substances. For the optimization of the pharmacological profile we selectively modified the structure of tranylcypromine (1a) by substitution on the cyclopropyl ring with a single fluorine atom. A series of tranylcypromine analogues with different substituent patterns and stereochemistry, such as 11a±d or 38 and its fluorinated analogue 30, were synthesized and their activities as inhibitors of monoamine oxidases were investigated and compared to other inhibitors. We herein summarize our recent results concerning the inhibitory activity of these fluorinated arylcyclopropylamines.

Efficient $\chi ^{2}$ Kernel Linearization Via Random Feature Maps.

Generalized Convexity-Based Inexact Projection Method for Multiple Kernel Learning

Sparse Random Projection for Χ2 Kernel Linearization: Algorithm and Applications to Image Classification

Self-representative kernel concept factorization

Distance-Based Classifier Via the Kernel Trick.

Additive Nearest Neighbor Feature Maps.

An Exact Finite-dimensional Explicit Feature Map for Kernel Functions

A Semismooth-Newton's-Method-Based Linearization and Approximation Approach for Kernel Support Vector Machines

Adaptive kernel subspace method for speeding up feature extraction

Fluorinated Phenylcyclopropylamines as Inhibitors of Monoamine Oxidases

A Large Dimensional Analysis of Least Squares Support Vector Machines

Learning Random Fourier Features by Hybrid Constrained Optimization

Unsupervised Discriminative Feature Selection in a Kernel Space Via L2, 1-Norm Minimization.

Linear Regression-Based Efficient SVM Learning for Large-Scale Classification.

A Support Vector Machine with a Hybrid Kernel and Minimal Vapnik-Chervonenkis Dimension

Random matrices meet machine learning: a large dimensional analysis of LS-SVM

Improved Random Features for Dot Product Kernels

Scaling the kernel function to improve performance of the support vector machine

An efficient Kernel-based matrixized least squares support vector machine

Data-Driven Linear Complexity Low-Rank Approximation of General Kernel Matrices: A Geometric Approach

Efficient Convex Algorithms for Universal Kernel Learning